Want to see SPRO full AI Analyst Report?

Spero Therapeutics (SPRO) Cash flow

604 Followers

Spero Therapeutics Cash Flow

SPRO's free cash flow for Q2 2026 was $-5.36M. For the 2026 fiscal year, SPRO's free cash flow was decreased by $10.82M and operating cash flow was $-5.36M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Operating Cash Flow	$ -12.62M	$ -23.44M	$ -32.99M	$ -7.73M	$ -64.35M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 33.81M	$ 7.67M
Financing Cash Flow	$ 0.00	$ 0.00	$ 221.00K	$ -29.55M	$ 84.05M
End Cash Position	$ 40.27M	$ 52.89M	$ 76.33M	$ 109.11M	$ 112.58M
Free Cash Flow	$ -12.62M	$ -23.44M	$ -32.99M	$ -7.73M	$ -64.35M

Currency in USD